S&P 500   3,667.23 (+1.26%)
DOW   29,895.90 (+0.87%)
QQQ   303.91 (+1.43%)
AAPL   122.79 (+3.14%)
MSFT   215.17 (+0.51%)
FB   288.15 (+4.04%)
GOOGL   1,811.38 (+3.25%)
AMZN   3,217.02 (+1.55%)
TSLA   581.30 (+2.41%)
NVDA   537.12 (+0.20%)
BABA   263.86 (+0.19%)
CGC   28.10 (-2.43%)
GE   10.34 (+1.57%)
MU   67.87 (+5.90%)
AMD   92.44 (-0.24%)
T   28.79 (+0.14%)
NIO   47.34 (-6.31%)
F   9.30 (+2.42%)
ACB   10.73 (-8.13%)
NFLX   504.41 (+2.79%)
BA   216.91 (+2.94%)
GILD   61.85 (+1.94%)
DIS   150.56 (+1.72%)
S&P 500   3,667.23 (+1.26%)
DOW   29,895.90 (+0.87%)
QQQ   303.91 (+1.43%)
AAPL   122.79 (+3.14%)
MSFT   215.17 (+0.51%)
FB   288.15 (+4.04%)
GOOGL   1,811.38 (+3.25%)
AMZN   3,217.02 (+1.55%)
TSLA   581.30 (+2.41%)
NVDA   537.12 (+0.20%)
BABA   263.86 (+0.19%)
CGC   28.10 (-2.43%)
GE   10.34 (+1.57%)
MU   67.87 (+5.90%)
AMD   92.44 (-0.24%)
T   28.79 (+0.14%)
NIO   47.34 (-6.31%)
F   9.30 (+2.42%)
ACB   10.73 (-8.13%)
NFLX   504.41 (+2.79%)
BA   216.91 (+2.94%)
GILD   61.85 (+1.94%)
DIS   150.56 (+1.72%)
S&P 500   3,667.23 (+1.26%)
DOW   29,895.90 (+0.87%)
QQQ   303.91 (+1.43%)
AAPL   122.79 (+3.14%)
MSFT   215.17 (+0.51%)
FB   288.15 (+4.04%)
GOOGL   1,811.38 (+3.25%)
AMZN   3,217.02 (+1.55%)
TSLA   581.30 (+2.41%)
NVDA   537.12 (+0.20%)
BABA   263.86 (+0.19%)
CGC   28.10 (-2.43%)
GE   10.34 (+1.57%)
MU   67.87 (+5.90%)
AMD   92.44 (-0.24%)
T   28.79 (+0.14%)
NIO   47.34 (-6.31%)
F   9.30 (+2.42%)
ACB   10.73 (-8.13%)
NFLX   504.41 (+2.79%)
BA   216.91 (+2.94%)
GILD   61.85 (+1.94%)
DIS   150.56 (+1.72%)
S&P 500   3,667.23 (+1.26%)
DOW   29,895.90 (+0.87%)
QQQ   303.91 (+1.43%)
AAPL   122.79 (+3.14%)
MSFT   215.17 (+0.51%)
FB   288.15 (+4.04%)
GOOGL   1,811.38 (+3.25%)
AMZN   3,217.02 (+1.55%)
TSLA   581.30 (+2.41%)
NVDA   537.12 (+0.20%)
BABA   263.86 (+0.19%)
CGC   28.10 (-2.43%)
GE   10.34 (+1.57%)
MU   67.87 (+5.90%)
AMD   92.44 (-0.24%)
T   28.79 (+0.14%)
NIO   47.34 (-6.31%)
F   9.30 (+2.42%)
ACB   10.73 (-8.13%)
NFLX   504.41 (+2.79%)
BA   216.91 (+2.94%)
GILD   61.85 (+1.94%)
DIS   150.56 (+1.72%)
Log in
CNSX:BIO

Bio-Rad Laboratories Price Target, Predictions & Analyst Ratings

Add
Compare
Today's Range N/A
50-Day Range
$0.06
MA: $0.08
$0.12
52-Week Range N/A
Volume265,600 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Bio-Rad Laboratories (CNSX:BIO) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Bio-Rad Laboratories in the last 12 months. Their average twelve-month price target is $0.65 The high price target for BIO is $0.65 and the low price target for BIO is $0.65. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
BIO Consensus Rating: BuyBuyBuyBuy
BIO Consensus Rating Score: 3.003.003.003.00
BIO Analyst Ratings: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
BIO Consensus Price Target: $0.65$0.65$0.65$0.65
BIO Price Target Upside: N/AN/AN/AN/A

Bio-Rad Laboratories (CNSX:BIO) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bio-Rad Laboratories (CNSX:BIO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
1/10/2020Fundamental ResearchLower Price TargetBuy ➝ Buy$1.31 ➝ $0.65
(Data available from 12/1/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.